![]() Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. | ![]() Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | ![]() OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | ||
Founding Date | Founding Date 2017 | Founding Date 1998 | Founding Date 2001 | Founding Date 1939 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations San Diego, US HQ | Locations Kawasaki, JP HQ | Locations Buenos Aires, AR HQ |
Employees | Employees 189 | Employees 373157% increase | Employees 54 | Employees 1,5382% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.4 b | Valuation ($) 56.9 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2024) | Revenue (est.) ¥610.1m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $159.4m (FY, 2024) | Cost of goods ¥787.8m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $855.9m (FY, 2024) | Gross profit (¥177.7m) (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income $444.1m (FY, 2024) | Net income (¥1.3b) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 171.9m | Total funding raised N/A | Total funding raised N/A |
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyOncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View companyElea Laboratories is a pharmaceutical company.
View company